Winette van der Graaf

We can finally hear the long-hidden music of the Stone Age Ancient rock art was meant to be heard as well as seen and now acoustic archaeologists are bringing the sounds of prehistoric rituals to life

Ancient rock art was meant to be heard as well as seen and now acoustic archaeologists are bringing the sounds of prehistoric rituals to life

YouTube video by ILFU Lieke Marsman op de 42ste Nacht van de Poëzie

Wat een indringende teksten en indrukwekkend optreden @liekemarsman.bsky.social
Ik loop wat achter op de feitelijke Nacht van de Poëzie 2025, maar deze inhoud is tijdloos.
Dank hiervoor en voor je prachtige werk- veel respect voor de Constantijn Huygens prijswinnaar 2025.

youtu.be/eyuI8tawHnE

📢 Big news from the SISAQOL-IMI Consortium! Their latest paper & new online materials are now live. This work will be key in improving how we measure patients' experiences in cancer care.

🔗 Read more in our press release: www.eortc.org/blog/2025/11...

#CancerResearch @qol.eortc.org @thelancet.com

EuropePMC.org is the alternative for PubMed, in case you have problems to access PubMed.

Convergence of science, regulations and society in cancer clinical research: A perspective based on the EORTC DE-ESCALATE Study - European Journal of Cancer www.ejcancer.com/article/
S0959-8049%2825%2900576-3/fulltext

Worth reading for all of you interested in patient centric trials in oncology with dose optimisation as important aim.
The challenges in the current European landscape.

#DE-ESCALATE #CTR

@eortc.org

doi: 10.1016/j.ejca.2025.115790

🎉 What a day at #EORTC #PatientDays!

Day 1 was packed with energy, empathy and honest round table talks.

Thanks to all who joined, your voices are shaping the future of cancer care.

👋 See you tomorrow!

🔗https://www.eortc.org/event/patient-days-2025/?tab=1
#CancerCare #PatientEngagement #Oncology

ESMO 2025: A leadership moment!

EORTC President @winettevandergraaf.bsky.social and incoming President @benjaminbessemd.bsky.social in action.
Sharing ideas, energy, and a vision for better cancer care across Europe.

Their presence at #ESMO25 says it all: Continuity Collaboration. Real impact.

The @eortc.org STBSG (sarcoma) group’s meeting in Lyon was a great success with a lot of ideas and interesting discussions.
Excellent talk about #ATLAS by
@saxotomy.bsky.social
Global trial options in rare diseases as #sarcoma possible!

What an amazing group op people in this consortium.
Grateful for everyone’s contribution!
@strong-aya.bsky.social
Annual meeting # Paris

📍 We're in Paris for the #STRONGAYA General Assembly meeting, hosted by Institut Gustave Roussy.

Today, we discussed:
• Sustaining project results & reaching stakeholders
• Ethical health data processing for research
• Patient consent models
• Evaluating & refining our Core Outcome Set

📖 New STRONG AYA Resource:
The Blueprint for building national and pan-European STRONG AYA ecosystems to improve AYA cancer care is now available on our website.

👉 Read the full blueprint with information on data ecosystem structures, governance, standards & challenges: strongaya.eu/wp-content/u...

Minimum standards of specialist adolescent and young adult (AYA) cancer care units: recommendations and implementation roadmap In 2022, according to the Global Cancer Observatory, >115 000 adolescents and young adults (AYAs; aged 15-39 years) were diagnosed with cancer across …

📄 Publication alert: Recommendations and roadmap to implement minimum standards of specialist adolescent and young adult #AYA cancer care units

Led and co-authored by AYAs under the EU-CAYAS-NET project and featuring STRONG-AYA among EU initiatives.
👉 www.sciencedirect.com/science/arti...

Grateful for the collaboration with @youthcancereurope.bsky.social showcasing minimal standards of AYA care units. Much can be found in the Dutch AYAZORGNETWERK.nl but we take the recoomendations into account to further improve the care. Published in @ESMO Open.

Very interesting session with speakers from Japan, India, Slovenia, Jordan, South Africa and South Korea.
Language matters, cultural sensitivity even more, particularly in Quality of Life Research. There’s work to do!

Happy to have introduced the topic showing other global activities @eortc.org

🔔 New in @thelancetoncol.bsky.social:
Policy review led by Ian Tannock & Madeline Pe with EORTC & CSO highlights the critical role of patient quality of life data in the evaluation of treatments for people with advanced cancer.
📖Read more: www.eortc.org/blog/2025/09...
#CancerResearch #QualityofLife

📅 Get ready to make the most of EORTC’s upcoming events!

Mark your calendars 👇

#CancerResearch #ClinicalTrials #Oncology #EORTCevents #PatientDays #EBCC15 #Stats2026 #MCCRworkshop #ENASymp26

Common Sense Oncology at ESMO. Join us at the Messe Berlin for a special CSO symposium. Panelists, from left to right: Dr. Winette van der Graaf, Dr. Chris Booth, Dr. Madeline Pe, Dr. Dario Trapani, Dr. Rachel Riechelmann, and Dr. Chris Cronin. Topics, from left to right: CSO and Clinical Trials, CSO Momentum, CSO and QOL, CSO and Education, CSO and Global Oncology, and CSO-EORTC Fellowship. Register now to receive location details.

📅 Attending ESMO in Berlin? Don't miss this special CSO Symposium taking place on Fri Oct 17, 5:30-7:00 pm CET.
Moderated by @winettevandergraaf.bsky.social, the panel will discuss recent CSO initiatives & activities in Europe & beyond.

tinyurl.com/5yj9vm8b

@qol.eortc.org #CommonSenseOncology

Queen's University. Common Sense Oncology Cancer Health Services Research Fellowship. Apply today to help build a cancer care system focused on outcomes that matter.

Applications for the 2026 Common Sense Oncology Cancer Health Services Research Fellowship will close on Sept 18, 2025 @ 4 pm EDT. If you are in the clinical or medical oncology field, this opportunity is for you!

View the posting online: tinyurl.com/37cdc5sy

#CommonSenseOncology #CancerCare

Leaders of Common Sense Oncology standing in front of the pillars of a building.

Common Sense Oncology is now on #BlueSky! We are a global network dedicated to advancing innovative patient-centred cancer care & cancer research that meaningfully improves outcomes for patients around the world.

Join us to keep in touch—membership is free!
tinyurl.com/mrjtu9at #CommonSenseOncology

Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation Oncology practitioners and health systems in sub-Saharan Africa need to be aware of the possible presence of substandard anticancer products when designing care protocols and evaluating patient outcom...

Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation - The Lancet Global Health www.thelancet.com/journals/lan...

This is awful.

📢Excited to announce @benjaminbessemd.bsky.social as EORTC President-Elect, starting in June 2026, following @winettevandergraaf.bsky.social 🙌

Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉

👉 www.eortc.org/blog/2025/06...

🔍Presenting at #ASCO25 as a #poster and now LIVE on our website

Predictors of withdrawal of anticancer drug indications granted accelerated approval: a retrospective cohort study

Read the whole paper here: www.thelancet.com/journals/ecl...
#TheLancet #Oncology #OncologyResearch #MedSky

Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer

Primary prophylactic G-CSF and loperamide led to a clinically relevant reduced incidence and severity of neutropenia and diarrhea

www.thelancet.com/journals/ecl...
#MedSky

For my #sarcoma colleagues and researchers and @HartwigMedicalFoundation @ecuppen.bsky.social

New paper on implementation of WGS in sarcoma routine medical care in a sarcoma expert center. WGS results of 161 STS were assessed. Actionable targets in 46%, subtype specific added value of WGS. Less in fusion pos STS, more in complex ones.

kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

Same disappointment. The early days of twitter were so informative! Let’s try harder here!

Immensely proud of my colleague and friend Christopher Booth @Queens’s University Kingston who will present the positive results of Challenge #ASCO25 today. Together with Publication in @nejm.org Impressive work. meetings.asco.org/2025-asco-an...

With dosing and duration that are investigated in clinical trials with relevant outcomes for patients reflecting the whole patient population, for regulators and health systems